Bristol-Myers Squibb gains approval for arthritis drug

December 27 2005

Orencia (abatacept) from Bristol-Myers Squibb gained U.S. regulatory approval for treating rheumatoid arthritis (RA).

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.